213 related articles for article (PubMed ID: 14984659)
1. Management of infectious complications in the hematopoietic stem cell transplant recipient.
Nichols WG
J Intensive Care Med; 2003; 18(6):295-312. PubMed ID: 14984659
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Combating infections in hematopoietic stem cell transplant recipients.
Nichols WG
Expert Rev Anti Infect Ther; 2003 Jun; 1(1):57-73. PubMed ID: 15482102
[TBL] [Abstract][Full Text] [Related]
4. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation: implications for critical care nurses.
Saria MG; Gosselin-Acomb TK
Clin J Oncol Nurs; 2007 Feb; 11(1):53-63. PubMed ID: 17441397
[TBL] [Abstract][Full Text] [Related]
6. Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.
Forslöw U; Mattsson J; Ringden O; Klominek J; Remberger M
Scand J Infect Dis; 2006; 38(11-12):970-6. PubMed ID: 17148063
[TBL] [Abstract][Full Text] [Related]
7. Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience.
Shimoni A; Nagler A
Curr Hematol Rep; 2004 Jul; 3(4):242-8. PubMed ID: 15217553
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of allogeneic hematopoietic stem cell transplantation-associated organizing pneumonia.
Jinta M; Ohashi K; Ohta T; Ieki R; Abe K; Kamata N; Akiyama H; Sakamaki H
Bone Marrow Transplant; 2007 Sep; 40(5):465-72. PubMed ID: 17618318
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution: the foundation for safe living after an allogeneic hematopoietic stem cell transplantation.
Laffan A; Biedrzycki B
Clin J Oncol Nurs; 2006 Dec; 10(6):787-94. PubMed ID: 17193944
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
11. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
12. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
Foss FM
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
[TBL] [Abstract][Full Text] [Related]
13. [Supportive therapy in patients with autologous hemopoietic stem cell transplantation].
Piatkowska-Jakubas B; Hawrylecka D; Wójcik M; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():108-14. PubMed ID: 10494191
[TBL] [Abstract][Full Text] [Related]
14. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
Castagnola E; Faraci M
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
Camps IR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
[TBL] [Abstract][Full Text] [Related]
16. Complications and risks in hematopoietic stem cell transplant patients.
Smith LA; Wright-Kanuth MS
Clin Lab Sci; 2001; 14(2):118-24. PubMed ID: 15625985
[TBL] [Abstract][Full Text] [Related]
17. Management of infections complicating allogeneic hematopoietic stem cell transplantation.
Hiemenz JW
Semin Hematol; 2009 Jul; 46(3):289-312. PubMed ID: 19549581
[TBL] [Abstract][Full Text] [Related]
18. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
[TBL] [Abstract][Full Text] [Related]
19. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
20. Preventing ventilator-associated pneumonia: evidence-based care.
Grap MJ; Munro CL
Crit Care Nurs Clin North Am; 2004 Sep; 16(3):349-58, viii. PubMed ID: 15358383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
